Author

Hermann Dietzfelbinger

Observed names: Dietzfelbinger, H., Dietzfelbinger, Hermann, H DIETZFELBINGER, H Dietzfelbinger, H F Dietzfelbinger, H. Dietzfelbinger, H., Dietzfelbinger, Hermann F. Dietzfelbinger

Observed institutions: TUM Klinikum, LMU Klinikum, Medizinische Hochschule Hannover, München Klinik Schwabing, Klinik Roderbirke, Marienhospital Stuttgart, Hanusch Hospital, University Hospital Münster, Hirslanden Private Hospital Group, Praxis für Hämatologie und Onkologie, Klinikum St. Marien Amberg, Technical University of Munich, Ludwig-Maximilians-Universität München

OpenAlex ID: A5108582846

Extramedullary plasmacytoma

1999 · Christoph Alexiou, Reinhardt J. Kau, et al. · Cancer · 596

PDF

Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia.

1999 · M Hallek, I Langenmayer, et al. · PubMed · 233

Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD)

1993 · Susanne Danhauser-Riedl, Edith Hausmann, et al. · Investigational New Drugs · 152

Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane

1995 · T. Schilling, K. B. Keppler, et al. · Investigational New Drugs · 148

An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine

2004 · U Jehn, R Bartl, et al. · Leukemia · 114

High-risk additional chromosomal abnormalities at low blast counts herald death by CML

2020 · Rüdiger Hehlmann, Astghik Voskanyan, et al. · Leukemia · 91

PDF

Second malignancies after Hodgkin's disease: the Munich experience

1999 · R. Munker, S. Grützner, et al. · Annals of Hematology · 50

Long-term outcome of hairy cell leukemia treated with 2-chlorodeoxyadenosine

1999 · U. Jehn, R. Bartl, et al. · Annals of Hematology · 31

Interferon‐alpha 2b (IFNα) for Early‐Phase Chronic Lymphocytic Leukaemia with High Risk for Disease Progression: Results of a Randomized Multicentre Study

1996 · Irmgard Langenmayer, Christoph Nerl, et al. · British Journal of Haematology · 25

Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation.

1993 · H F Dietzfelbinger, D Kühn, et al. · PubMed · 23

Randomized trial comparing cetuximab plus XELIRI versus cetuximab plus XELOX as first line treatment of patients with metastatic colorectal cancer (mCRC): A study of the german AIO CRC study group

2008 · V. Heinemann, L. Fischer von Weikersthal, et al. · Journal of Clinical Oncology · 14

[Clinical observations to characterize splenomegalic immunocytomas (author's transl)].

1977 · H Theml, A Burger, et al. · PubMed · 12

Romiplostim for Primary Immune Thrombocytopenia in Routine Clinical Practice: Results from a Multicentre Observational Study in Germany

2021 · Marcel Reiser, Klaus M. Josten, et al. · Acta Haematologica · 11

Cetuximab + capecitabine + irinotecan (CCI) versus cetuximab + capecitabine + oxaliplatin (CCO) as first line therapy for patients with metastatic colorectal cancer (CRC): Preliminary results of a randomized phase II trial of the AIO CRC Study Group

2006 · V. Heinemann, L. Fischer Von Weikersthal, et al. · Journal of Clinical Oncology · 11

Differential cytotoxicity of an ether lipid on lymphoma and bone marrow cells and its role in purging malignant lymphoid cells from remission bone marrow contaminated with tumor cells.

1992 · H F Dietzfelbinger, A Lang, et al. · PubMed · 11

Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML

2020 · Rüdiger Hehlmann, Astghik Voskanyan, et al. · Leukemia · 6

PDF

Patientenrekrutierung und Ergebnisse einer Vorphasestudie zur Therapie der akuten lymphatischen Leukämie und der akuten undifferenzierten Leukämie des Erwachsenen

2009 · D. Hoelzer, E. Thiel, et al. · Onkologie · 6

Hämolytische Anämien und Vitamin-B12-Mangel

2015 · Hermann Dietzfelbinger, Max Hubmann · DMW - Deutsche Medizinische Wochenschrift · 2

PDF

Eisenstatus und Eisenbedarf bei Blutspendern

2009 · P. Nielsen, H. Dietzfelbinger, et al. · Infusionstherapie und Transfusionsmedizin / Infusion Therapy and Transfusion Medicine · 2

Kriterien der Lebensqualität

2013 · Hermann Dietzfelbinger, Pia Heußner · Elsevier eBooks · 1

Potenzielle Überforderung von Patient und Arzt

2013 · Hermann Dietzfelbinger · Elsevier eBooks · 1

Interdisziplinäre Kooperation

2013 · Hermann Dietzfelbinger, Monika Dorfmüller · Elsevier eBooks · 1

Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: An analysis of the AIO KRK 0104 trial.

2012 · Dominik Paul Modest, Ruediger Paul Laubender, et al. · Journal of Clinical Oncology · 1

lnterferon-alpha2b for Early Phase Chronic Lymphocytic Leukemia with High Risk for Progression – First Results of a Randomized Multicenter AlO-Study

2009 · W. Knauf, l. Langenmayer, et al. · Onkologie · 1

Risiko-adaptierte Therapie hochmaligner Non-Hodgkin Lymphome mit COP-BLAM/IMVP-16: Eine prospektive multizentrische Studie

2009 · H.H. Gerhartz, W. Wilmanns, et al. · Onkologie · 1

Works count: 63

Citation count: 1,546

H-index: 12

I10-index: 15